Feedback Share Discussion Threads

[yump] 22/10/2019 09:52

The nhs have in recent years issued various edicts about adopting new stuff at ‘pace and scale’. Last document i saw was 32 pages long which is very ironic ;-)

[ged5] 22/10/2019 09:45

Ah, I'm with you now, thanks.

[yump] 22/10/2019 09:39

Basically the nhs seems to have a structural problem in deciding who pays when more than one area within it is going to benefit. If its just one department the budget is easily allocated. So businesses selling in can get caught up in either multiple negotiations with different departments and hospitals or drawn out ones with central budget holders. At least thats my understanding.

Theres also a best practice bureaucracy at work which is sensible with clinical practices, but can get in the way if buying A4 paper.

Thats my gloomy downside i guess !

This is a simple product really though, so perhaps the process will be much easier.

As they said though, there are multiple markets here, established relationships and probably more than one route in

[ged5] 22/10/2019 09:26

Indeed it is interesting, Bob. Lets hope the hard work is rewarded.

I'm not sure I follow your post, Yump.

Quiet morning so far.

[dave4545] 22/10/2019 08:19

1.2861-1.3289p

The 1.31p stock has gone now, time to push on providing all the stale sellers are
out now

[yump] 21/10/2019 22:54

Hopefully even if the budgets are a bit of an issue (eg silos) and deciding who pays, at least its not subject to medical requirements other than patient data protection. I hope it doesnt get into the usual issue of problems deciding who pays when everyone benefits. That is a farcical situation at times, but it still happens.

[ducatiman] 21/10/2019 20:55

Ged, if clinicians ask for it!

[hazl] 21/10/2019 20:23

It's great there is at last some enthusiasm om the alternative thread....fairly obvious why....to me anyway. 8-)

[bobd29] 21/10/2019 19:25

It’s interesting Ged5 isn’t it? TO’s Statement is quite definitive ie: ‘there’s an awful lot happening on that front’. Clearly talks are moving forward and not just in the NHS, we know trials are in hand and I suspect FDBK are seeing just how big this could be. If we can generate income in the next 6 months to help funding then for me the corner has been turned and growth will be exponential. Staffing constraints to handle all the enquires would be a nice problem to have. Cheap at present but for how much longer?

[ged5] 21/10/2019 17:24

Where do young people get their energy from? I'm shattered!

Yump, you stated:-

" Whether its as simple as just selling a consumer product to a lot of clinicians I don't know."

At the end of the last interview when he was asked what was to come, Tom Oakley stated:-

"Announce NHS sites where Bleepa is up and running and potentially outside the NHS There’s an awful lot happening on that front but given the complexity of the NHS not sure how quickly."

Also on the Bleepa FAQ:-

"To maximise the utility of Bleepa it is envisaged that a whole department or hospital will invest to allow everyone to benefit from it."

So I don't think it's quite as simple as selling to a lot of clinicians. Apparently it was well received by clinicians and NHS Senior Managers so we'll have to see how he deals with the perceived complexity.

[yump] 21/10/2019 11:49

Thanks for the welcome.

I have some shares in DEMG (medical device) which has proved a disaster, but that was a complex medical device used on patients. On reflection, a silly investment with too much to get in the way of sales.

If management here has improved and they've now got an easyish sell...
Pilots first though, but they can't be very complicated - which should make it easier for NHS management or whoever to just say 'yes - go ahead'. Famous last words I hope not !

[yump] 21/10/2019 11:44

Quite prepared to sit on early stage businesses, if the model looks straightforward. Often it isn't ! There's loads of interesting new products and services around, but many don't have real USP's and quite a few are involved in proof of concept and viability which can take ages, especially if they involve third parties.

This looks a lot more straightforward than most. Whether its as simple as just selling a consumer product to a lot of clinicians I don't know.

[bobd29] 21/10/2019 11:42

Hi yump, welcome. I have been a lth here and I echo Ged5’s remarks. In my opinion the share price does not even reflect asset (IP) value at present looking at Cadran, TexRAD and Bleepa with a mcap of only £5m. Given the potential of Bleepa within and outside the NHS, and outside the medical realm for that matter, also the prospect of TexRAD possibly getting FDA approvaland clinical sales/JVs, there is considerable upside and little downside risk imo. That said the history of commercial management has been poor, but we now have a new team so hopefully that improves. Good luck.

[ged5] 21/10/2019 10:44

I must have been typing when you posted, Yump.

Welcome. I've seen you post in the past on other threads and am aware that you research companies you invest in. Good to have you on board.

Yes, Tom Oakley stated that Cadran, the PACS system, was in a competitive space and that is why he introduced Bleepa.

Bleepa is the clinical grade imaging, data secure system. Pilots hospitals are close to being secured. After that hopefully if things go well contracts will start.

TexRAD is texture analysis and has plenty of potential. TO is working on this at the moment and he's said we should hear by the end of the year.

Results out soon. Don't expect too much. This is a very small company at the moment and the results should show revenue of only about 565K.

Early days but I for one have plenty of hope.

[ged5] 21/10/2019 10:32

Thanks LR2.

All quiet again after such an exciting start to the week. ;)

The sun is shining so time to take the grandchildren into the garden and later to the beach.

[yump] 21/10/2019 10:31

Been looking at this for quite a while but never bought, having vowed not to buy into any sort of medical device business because of the barriers and bureaucracy the NHS introduces. (Got caught in the past with 'great' products that just didn't get any traction despite various approvals).

Also, they themselves mention that they're in a competitive space with their other products.

However, this latest news looks a bit different. It seems a very simple thing (even if the tech is tricky), with a simple objective, that solves a problem that really exists. Has it got a simple sales path ? that's what I can't work out.

Had a small purchase anyway. There is going to be newsflow, that's certain.

[dave4545] 21/10/2019 09:45

It should have been over 1.5p anyway from last weeks update but when you get the wrong crowd in which is the mugs that follow topinfo you get idiots that buy then refuse to hold and sell for a loss, they keep the mm's happy around 1.22p bid but once they exhaust the investors win the battle which is happening now.

[lr2] 21/10/2019 09:44

Sell 550k at 1.3005p (small amounts at 1.311p)
Buy 375k at 1.349p (small amounts at 1.34p)

[hazl] 21/10/2019 09:39

Hmm... sudden interest again.
Twitter?
Or something real?

[ged5] 21/10/2019 09:30

So what was the million trade? I assume a buy to move the sp!

[dave4545] 21/10/2019 09:08

There's no stock Ged5. 50k is N/T so fill or kill only.

That pump and dump parasite on twitter toptradersadvfn ramped this s last week which meant it was swamped by day traders who all sold back again Thursday and Friday, now they are all gone it's back to normal business and the price should be trading above 1.5p anyway now so it's heading there again albeit slowly.

[ged5] 21/10/2019 09:04

lol

Very quiet here now. Very low volume yet a small buy happened to move the share price

[dave4545] 21/10/2019 09:02

No stock available at 1.3p currently online.

The mm's have played the day traders from last week, now ready to move upwards again

[ducatiman] 20/10/2019 18:04

I believe that things are going to get very interesting here soon.